Is Boston Scientific (BSX) One of the Best Healthcare Stocks to Buy With the Highest Upside Potential?

Boston Scientific Corporation (NYSE:BSX) besides received a standing update from BofA successful a abstracted development. BofA chopped the terms people connected Boston Scientific Corporation (NYSE:BSX) to $68 from $105 connected May 18, reaffirming a Buy standing connected the shares. The steadfast told investors that aft having hosted 34 medtech companies past week successful Las Vegas, it updated respective terms targets for "the caller world of medtech valuations" successful a twelvemonth of fewer merchandise cycles, ostentation kicking up post-war, ACA, and utilization worries, and "data centers implicit healthcare".

Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets aesculapian devices utilized successful interventional aesculapian procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular conception covers Cardiology and Peripheral Interventions, portion the MedSurg conception comprises Urology, Endoscopy, and Neuromodulation.

While we admit the imaginable of BSX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey connected Google News.